A recent report by Forbes.com highlights the tremendous growth expected in the cannabidiol (CBD) market over the next three years. The report also explains that hemp-derived CBD will account for $450 million of the estimated total sales of $2.1B by 2020.
As quoted in the report:

The cannabidiol (CBD) market is estimated to grow by 700% by 2020, according to Forbes. A new report by market intelligence firm Hemp Business Journal projects that the CBD market will grow to $2.1 billion by 2020, an astronomical jump in value compared to last year’s CBD market of $202 million.
CBD is one of the more than 85 cannabinoids so far identified in marijuana and hemp. Unlike the better-known compound tetrahydrocannabinol (THC), CBD is not psychoactive, meaning it won’t cause a high. Thousands of studies have shown that CBD possesses an array of therapeutic benefits, including antioxidant and neuroprotective properties.
“In terms of the CBD market size, I estimate an almost $3 billion market by 2021. Right now there are 15 states that allow CBD only — this is in addition to the 28 states plus DC that have legalized medical marijuana,” Matt Karnes of Greenwave Advisors told Forbes, believing the growing CBD market will exceed the estimations by Hemp Business Journal.
The Hemp Business Journal report estimates that $450 million of the projected $2.1 billion in sales by 2020 will come from hemp-based sources. The hemp-derived CBD market was $90 million in 2015.
CBD that is derived from hemp is legal to import and purchase in all 50 U.S. states, without a prescription. Cannabidiol itself isn’t listed in the Controlled Substances Act like THC and marijuana.
Current market leader Medical Marijuana, Inc. told Forbes that it pulls in over $800,000 in retail hemp-based CBD sales per month. The company’s sales are expected to be $9 million in 2016, up from $3.4 million in 2013.
Being the only CBD company on the market at the time, Medical Marijuana, Inc. reached $14.5 million in sales in 2014, and while their customer count has increased since then, an increase in competition and a drop in prices has affected sales figures. Its investment company, Axim Biotechnologies, holds a patent and license for a CBD chewing gum called CanChew.
Venture capital firm General Hemp, which has controlling interest in Medical Marijuana, Inc., made $34 million in CBD sales between 2014 and 2016, not including Medical Marijuana, Inc. companies.
With the recent influx in competition and a lack of regulation, consumers must educate themselves to ensure they buy high-quality CBD. Medical Marijuana, Inc. says that the CBD oil used in its Real Scientific Hemp Oil and Dixie Botanicals products is derived from hemp grown in Austria and that it’s tested several times for purity and cannabinoid content.
According to Forbes, data from Headset Research says that it’s difficult for consumers to know what they’re getting when they purchase CBD products. The information offered on most product labels is limited.
“Many order large vats of CBD oil that is produced from Chinese industrial hemp and cut that into their products. This makes it difficult for those who grow and extract CBD locally to compete and consumers aren’t currently educated enough to have a preference for ‘homegrown’ CBD products.”
The best play for consumers is “to do their homework,” Forbes suggests, by looking into where a company acquires its CBD. Finding out which products are best will likely include trial and error, the publication says.


 

World High Life Plc (“World High Life” or the “Company”)(AQSE:LIFE) (OTCQB:WRHLF), is pleased to announce that it has appointed H&P Advisory Limited (“Hannam & Partners”) as financial advisor to the Company with immediate effect

About Love Hemp

Keep reading... Show less

Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of Rise™ retail stores, today announced that its executive team will participate in the following conference in March 2021:

Needham 2 nd Annual Virtual Cannabis Conference, March 3, 2021: Management will participate in one-on-one meetings.

Keep reading... Show less

In the cannabis space this week, retailer Fire & Flower Holdings (TSX:FAF,OTCQX:FFLWF) told investors it will be entering the US market through a novel strategic action.

Meanwhile, two longstanding cannabis partners ended their relationship.

Keep reading... Show less

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less